» Articles » PMID: 26142932

Effects of a 10-day Course of a High Dose Calciferol Versus a Single Mega Dose of Ergocalciferol in Correcting Vitamin D Deficiency

Overview
Journal Ann Saudi Med
Specialty General Medicine
Date 2015 Jul 6
PMID 26142932
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: The correction of vitamin D deficiency is crucial for optimal skeletal and non-skeletal health. Most regimens in current use are based on daily dosing, which may raise concerns of dosage inadequacy and suboptimal patient compliance. Vitamin D is available in 2 forms: D2 (ergocalciferol) and D3 (cholecalciferol). It has been reported that D2 supplements are less effective and may enhance the degradation of 25-hydroxyvitamin D3 (25[OH]D3) metabolite. The aim of this study was to compare the effect of 2 high-dose oral vitamin D regimens--a 10-day course of D3 500,000 IU versus a single mega dose of 600,000 IU D2--on serum 25(OH)D levels.

Design And Settings: A prospective cohort study was conducted from September 2010 to February 2011 in an urban university tertiary hospital in Amman, Jordan.

Patients And Methods: A total of 109 patients aged 18 to 79 years were enrolled with severe vitamin D deficiency. Fifty-one subjects received 600,000 IU D2 orally and 54 subjects received a total dose of 500,000 IU D3 administered orally, as 50,000 IU D3 daily for 10 consecutive days. Baseline and follow-up total serum 25(OH)D, 25(OH)D2, and 25(OH)D3 levels were compared.

Results: The mean total 25(OH)D increment from baseline was 10.33 (5.68) ng/mL over a mean of 43.08 (2.81) days for the D2 group. The mean increment in 25(OH)D for the D3 group was 47.03 (23.67) ng/mL over a mean of 36.9 (2.9) days. The difference between the 2 mean increments was highly significant: P=3.15.10-18. The 600,000 IU D2 single mega-dose decreased 25(OH)D3 levels by an average of 4 ng/mL in 37 subjects.

Conclusion: Overall, the 10-day oral D3 regimen rapidly and effectively normalized 25(OH)D levels. The shortened dosing interval over 10 consecutive days might result in higher compliance.

Citing Articles

Association of vitamin D status with COVID-19 and its severity : Vitamin D and COVID-19: a narrative review.

Bae J, Choe H, Holick M, Lim S Rev Endocr Metab Disord. 2022; 23(3):579-599.

PMID: 34982377 PMC: 8724612. DOI: 10.1007/s11154-021-09705-6.


Vitamin-D2 treatment-associated decrease in 25(OH)D3 level is a reciprocal phenomenon: a randomized controlled trial.

Hammami M, Abuhdeeb K, Hammami S, Yusuf A BMC Endocr Disord. 2019; 19(1):8.

PMID: 30658603 PMC: 6339397. DOI: 10.1186/s12902-019-0337-8.


Differential effects of vitamin D2 and D3 supplements on 25-hydroxyvitamin D level are dose, sex, and time dependent: a randomized controlled trial.

Hammami M, Yusuf A BMC Endocr Disord. 2017; 17(1):12.

PMID: 28231782 PMC: 5324269. DOI: 10.1186/s12902-017-0163-9.

References
1.
Holick M, Biancuzzo R, Chen T, Klein E, Young A, Bibuld D . Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 2007; 93(3):677-81. PMC: 2266966. DOI: 10.1210/jc.2007-2308. View

2.
Holick M . The vitamin D epidemic and its health consequences. J Nutr. 2005; 135(11):2739S-48S. DOI: 10.1093/jn/135.11.2739S. View

3.
Gorham E, Garland C, Garland F, Grant W, Mohr S, Lipkin M . Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med. 2007; 32(3):210-6. DOI: 10.1016/j.amepre.2006.11.004. View

4.
Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

5.
Armas L, Hollis B, Heaney R . Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004; 89(11):5387-91. DOI: 10.1210/jc.2004-0360. View